CompletedPhase 2NCT01045772
Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)
Studying Muckle-Wells syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Charite University, Berlin, Germany
- Principal Investigator
- Marcus Maurer, MDAllergie-Centrum-Charité, Charité University Berlin, Germany
- Intervention
- rilonacept(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2010
Study locations (1)
- Charité University Hospital, Berlin, State of Berlin, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01045772 on ClinicalTrials.gov